Key Record Dates Identifier: NCT03272477
Brief Title: Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (TP-II)

First Submitted : August 10, 2017
First Submitted that Met QC Criteria : September 1, 2017
First Posted : September 5, 2017

Last Update Submitted that Met QC Criteria : May 29, 2019
Last Update Posted : May 30, 2019